← Back to all trials
Suspended
NCT05606315
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery
Conditions: Sedation, ICU, Remimazolam Besylate
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 117
Sponsor: Nanfang Hospital, Southern Medical University
Location: Southern medical university Nanfang hospital Guangzhou Guangdong
Summary
Remimazolam besylate, as a new benzodiazepine drug, showing rapid clearance and moderate distribution of pharmacokinetic changes. The study will further explore the safety and effectiveness of remimazolam besylate n the sedation of mechanically ventilated patients after oral and maxillofacial surgery in the ICU.
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years old;
* After undergoing oral and maxillofacial surgery, it is expected that a ventilator will be needed to assist with breathing;
* mechanical ventilation patients with expected ICU stay time \
Source: ClinicalTrials.gov (NCT05606315). StuddyBuddy aggregates publicly available trial information.
